敏芯股份(688286.SH):就共設產業投資基金“MEMS投資中心”等 與相關方正式簽署合夥協議
格隆匯 3 月 9日丨敏芯股份(688286.SH)公佈,近日,經過各方的友好協商,就共同投資設立產業投資基金“MEMS投資中心”即蘇州園芯的具體細節事宜達成一致;公司與園豐資本受託管理的基金蘇州工業園區產業投資基金(有限合夥)(“園區產業基金”)、中新創投、納米公司以及蘇州順融投資管理有限公司(“順融投資”)正式簽署《合夥協議》,截至公吿披露日,蘇州園芯尚未完成工商註冊登記手續,且尚未在中國證券投資基金業協會辦理備案登記。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.